SCHEMBL1704301

SCHEMBL1704301

CC(C)(C)[Si](C)(O[Si](C)(C(C)(C)C)C(C)(C)C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10940845 0.85
SCHEMBL5668094 0.79
SCHEMBL28217194 0.72 ALDH1A1 (0.31)
SCHEMBL12971278 0.69
SCHEMBL8278 0.67
SCHEMBL5609364 0.64
SCHEMBL729499 0.64
Hydrochloric Acid SCHEMBL16047936 0.64
SCHEMBL1002050 0.62
SCHEMBL7764998 0.62 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1889840-A1 Rearrangement of spirolactams LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2008-02-20 EP claimed
WO-2008009695-A1 REARRANGEMENT OF SPIROLACTAMS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2008-01-24 WO claimed
US-12492180-B2 Process and intermediates for the preparation of Voxelotor CURIA SPAIN, S.A.U. (ES) 2025-12-09 US disclosed
US-12006311-B2 Compounds for use in preventing or treating cancer FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA (ES) 2024-06-11 US disclosed
CN-113365992-B Process and intermediates for the preparation of Wo Sailuo torr 晶体制药独资有限公司 2024-05-28 CN disclosed
EP-4356909-A1 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF Selabtec Sciences, SLU (ES) 2024-04-24 EP disclosed
WO-2024074604-A1 COMPOUNDS FOR THE MANAGEMENT OF CELL STEMNESS AND INVASION IN CANCER AND RELATED DISEASES INSTITUTO BIOMAR, S.A (ES) 2024-04-11 WO disclosed
EP-4349409-A1 COMPOUNDS FOR THE MANAGEMENT OF CELL STEMNESS AND INVASION IN CANCER AND RELATED DISEASES Instituto Biomar S.A. (ES) 2024-04-10 EP disclosed
US-20240074301-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-02-29 US disclosed
EP-3969459-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF ELDECALCITOL FAES FARMA SA (ES) 2023-08-23 EP disclosed
WO-2023118045-A1 PROCESS FOR THE CONTROLLED SYNTHESIS OF VOCLOSPORIN CURIA SPAIN, S.A.U. (ES) 2023-06-29 WO disclosed
WO-2005108356-A1 SPIROLACTAMS AND THEIR SYNTHESIS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2005-11-17 WO disclosed
WO-2005108357-A1 REGIOSELECTIVE FUNCTIONALISATION AND PROTECTION OF SPIROLACTAMS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2005-11-17 WO disclosed
EP-1412346-B1 METHOD FOR PRODUCING NOVEL SPINOSYN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2005-03-09 EP disclosed
US-20040260043-A1 Olefin polymerization catalyst system useful for polar monomers EXXONMOBIL CHEMICAL PATENTS, INC. 2004-12-23 US disclosed
WO-2004101634-A1 OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-11-25 WO disclosed
EP-1070052-A1 FUNGICIDE COMPOSITIONS COMPRISING A HYDROXIMIC OR HYDRAZONIC GROUP AVENTIS CROPSCIENCE S.A. (FR) 2001-01-24 EP disclosed
WO-1999051579-A1 FUNGICIDE COMPOSITIONS COMPRISING A HYDROXIMIC OR HYDRAZONIC GROUP AVENTIS CROPSCIENCE S.A. (FR) 1999-10-14 WO disclosed
US-4777271-A Isocarbacyclin derivatives and process for production thereof SAGAMI CHEMICAL RESEARCH CENTER (JP) 1988-10-11 US disclosed
EP-0247202-A1 ISOCARBACYCLIN DERIVATIVES AND PROCESS FOR THEIR PREPARATION SAGAMI CHEMICAL RESEARCH CENTER (JP) 1987-12-02 EP disclosed